Premium
The regulation of the UK pharmaceutical industry: A cost‐benefit analysis
Author(s) -
Hartley Keith,
Maynard Alan
Publication year - 1982
Publication title -
managerial and decision economics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 51
eISSN - 1099-1468
pISSN - 0143-6570
DOI - 10.1002/mde.4090030304
Subject(s) - pharmaceutical industry , product (mathematics) , industrial organization , business , economics , public economics , microbiology and biotechnology , geometry , mathematics , biology
Regulation is not costless. It can have adverse effects on innovation, on the time required to develop a new product and on an industry's competitiveness. This article estimates the costs of regulating the UK pharmaceutical industry and whether the results are worthwhile.